SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 4 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2012. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $36,000 | +24.1% | 220 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $29,000 | +81.2% | 220 | 0.0% | 0.00% | – |
| Q1 2018 | $16,000 | 0.0% | 220 | -24.1% | 0.00% | – |
| Q4 2017 | $16,000 | -86.0% | 290 | -90.3% | 0.00% | -100.0% |
| Q2 2013 | $114,000 | +10.7% | 3,000 | -25.0% | 0.00% | 0.0% |
| Q1 2013 | $103,000 | +98.1% | 4,000 | +100.0% | 0.00% | +100.0% |
| Q4 2012 | $52,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 290,000 | $44,066,000 | 9.14% |
| Avoro Capital Advisors LLC | 1,400,000 | $212,730,000 | 7.35% |
| NEXTHERA CAPITAL LP | 50,317 | $7,646,000 | 6.37% |
| Eventide Asset Management | 1,123,000 | $170,640,000 | 5.19% |
| RTW INVESTMENTS, LP | 604,236 | $91,814,000 | 4.90% |
| Casdin Capital, LLC | 335,000 | $50,903,250,000 | 4.76% |
| Copernicus Capital Management, LLC | 30,000 | $4,559,000 | 4.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 548,500 | $83,345,000 | 3.76% |
| Dynamic Capital Management Ltd | 4,677 | $711,000 | 3.54% |
| Camber Capital Management LP | 500,000 | $75,975,000 | 3.54% |